These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 27879354)

  • 1. Ablation of the Duodenal Mucosa as a Strategy for Glycemic Control in Type 2 Diabetes: Role of Nutrient Signaling or Simple Weight Loss.
    Garvey WT
    Diabetes Care; 2016 Dec; 39(12):2108-2110. PubMed ID: 27879354
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of the Duodenal-Jejunal Bypass Liner on Glycemic Control in Patients With Type 2 Diabetes With Obesity: A Meta-analysis With Secondary Analysis on Weight Loss and Hormonal Changes.
    Jirapinyo P; Haas AV; Thompson CC
    Diabetes Care; 2018 May; 41(5):1106-1115. PubMed ID: 29678867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Duodenal-Jejunal Bypass Surgery on Glycemic Control in Type 2 Diabetes: A Randomized Controlled Trial.
    Petry TZ; Fabbrini E; Otoch JP; Carmona MA; Caravatto PP; Salles JE; Sarian T; Correa JL; Schiavon CA; Patterson BW; Cohen R; Klein S
    Obesity (Silver Spring); 2015 Oct; 23(10):1973-9. PubMed ID: 26414562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shifts in intestinal microbiota after duodenal exclusion favor glycemic control and weight loss: a randomized controlled trial.
    Cortez RV; Petry T; Caravatto P; Pessôa R; Sanabani SS; Martinez MB; Sarian T; Salles JE; Cohen R; Taddei CR
    Surg Obes Relat Dis; 2018 Nov; 14(11):1748-1754. PubMed ID: 30174193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocrine effects of duodenal-jejunal exclusion in obese patients with type 2 diabetes mellitus.
    Kaválková P; Mráz M; Trachta P; Kloučková J; Cinkajzlová A; Lacinová Z; Haluzíková D; Beneš M; Vlasáková Z; Burda V; Novák D; Petr T; Vítek L; Pelikánová T; Haluzík M
    J Endocrinol; 2016 Oct; 231(1):11-22. PubMed ID: 27474690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic Effects of Endoscopic Duodenal Mucosal Resurfacing: a Systematic Review and Meta-analysis.
    de Oliveira GHP; de Moura DTH; Funari MP; McCarty TR; Ribeiro IB; Bernardo WM; Sagae VMT; Freitas JR; Souza GMV; de Moura EGH
    Obes Surg; 2021 Mar; 31(3):1304-1312. PubMed ID: 33417100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endoscopic duodenal mucosa ablation: the future of diabetes treatment?
    Musso G; Cassader M; Gambino R
    Trends Mol Med; 2024 Jul; 30(7):612-616. PubMed ID: 38553333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of blood glucose control after small intestine exclusion surgery in Goto-Kakizaki rat with type 2 diabetes mellitus].
    Wang Y; Zhang ZZ; Wang L; Deng ZZ; Jiao YB; Zou ZD
    Zhonghua Yi Xue Za Zhi; 2009 Nov; 89(40):2858-61. PubMed ID: 20137669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exclusion of the Distal Ileum Cannot Reverse the Anti-Diabetic Effects of Duodenal-Jejunal Bypass Surgery.
    Chai J; Zhang G; Liu S; Hu C; Han H; Hu S; Zhang Z
    Obes Surg; 2016 Feb; 26(2):261-8. PubMed ID: 26024737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preserving Duodenal-Jejunal (Foregut) Transit Does Not Impair Glucose Tolerance and Diabetes Remission Following Gastric Bypass in Type 2 Diabetes Sprague-Dawley Rat Model.
    Dolo PR; Yao L; Li C; Zhu X; Shi L; Widjaja J
    Obes Surg; 2018 May; 28(5):1313-1320. PubMed ID: 29098544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety experience with the duodenal-jejunal bypass liner: an endoscopic treatment for diabetes and obesity.
    Betzel B; Koehestanie P; Aarts EO; Dogan K; Homan J; Janssen IM; Wahab PJ; Groenen MJ; Berends FJ
    Gastrointest Endosc; 2015 Nov; 82(5):845-52. PubMed ID: 25952090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydrothermal Duodenal Mucosal Resurfacing: Role in the Treatment of Metabolic Disease.
    Cherrington AD; Rajagopalan H; Maggs D; Devière J
    Gastrointest Endosc Clin N Am; 2017 Apr; 27(2):299-311. PubMed ID: 28292408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and Effectiveness of an Endoscopically Placed Duodenal-Jejunal Bypass Device (EndoBarrier®): Outcomes in 114 Patients.
    Forner PM; Ramacciotti T; Farey JE; Lord RV
    Obes Surg; 2017 Dec; 27(12):3306-3313. PubMed ID: 29018990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycemic control after stomach-sparing duodenal-jejunal bypass surgery in diabetic patients with low body mass index.
    Cohen R; Caravatto PP; Correa JL; Noujaim P; Petry TZ; Salles JE; Schiavon CA
    Surg Obes Relat Dis; 2012; 8(4):375-80. PubMed ID: 22410638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endoscopic Therapeutic Option for Weight Loss and Control of Type 2 Diabetes: the Duodenal-Jejunal Bypass Liner.
    de Moura EG; Orso IR; Martins BC; Lopes GS
    Surg Technol Int; 2015 May; 26():115-9. PubMed ID: 26054998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beneficial Metabolic Effects of Duodenal Jejunal Bypass Liner for the Treatment of Adipose Patients with Type 2 Diabetes Mellitus: Analysis of Responders and Non-Responders.
    Stratmann B; Krepak Y; Schiffer E; Jarick I; Hauber M; Lee-Barkey YH; Fischer M; Tschoepe D
    Horm Metab Res; 2016 Sep; 48(10):630-637. PubMed ID: 27589345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duodenal-jejunal bypass attenuates progressive failure of pancreatic islets in streptozotocin-induced diabetic rats.
    Wang T; Zhang P; Zhang X; Cao T; Zheng C; Yu B
    Surg Obes Relat Dis; 2017 Feb; 13(2):250-260. PubMed ID: 27865809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duodenal long noncoding RNAs are associated with glycemic control after bariatric surgery in high-fat diet-induced diabetic mice.
    Liang Y; Yu B; Wang Y; Qiao Z; Cao T; Zhang P
    Surg Obes Relat Dis; 2017 Jul; 13(7):1212-1226. PubMed ID: 28366671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role and mechanism of duodenal-jejunal bypass in the management of type 2 diabetes mellitus].
    Hu C; Liu S; Hu S
    Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Jul; 17(7):635-8. PubMed ID: 25070437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compared to Sleeve Gastrectomy, Duodenal-Jejunal Bypass with Sleeve Gastrectomy Gives Better Glycemic Control in T2DM Patients, with a Lower β-Cell Response and Similar Appetite Sensations: Mixed-Meal Study.
    Zachariah PJ; Chen CY; Lee WJ; Chen SC; Ser KH; Chen JC; Lee YC
    Obes Surg; 2016 Dec; 26(12):2862-2872. PubMed ID: 27138599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.